Schrape S, Jones D B, Wright D H
Br J Cancer. 1987 Mar;55(3):283-6. doi: 10.1038/bjc.1987.54.
The proliferation rate of non-Hodgkin's lymphomas (NHL) was estimated by using 3 different methods. In cell suspension we determined the proportion of cells in cycle with the monoclonal antibody (Mab) Ki-67 and also in S-phase after the incorporation of bromo-deoxyuridine (BrdU) utilizing Mab anti-BrdU. In low grade lymphomas 3.5 +/- 1.6% of the cells were in cycle and 1.2 +/- 0.9% in S-phase, the corresponding values for high grade lymphomas were 22.5 +/- 18.7% and 8.9 +/- 7.8% respectively. Frozen sections of NHL were reacted with an antibody to the transferrin receptor (TR) and Ki67 as markers for proliferative activity. A high number of TR positive cells was found in low grade lymphomas of all histological types, whereas Ki67 positivity correlated closely with grading. With a few exceptions, low grade lymphomas contained less than 25% Ki67 positive cells within the tumour cell population. This observation is relevant to treatment strategies for low grade NHL.
采用3种不同方法估算非霍奇金淋巴瘤(NHL)的增殖率。在细胞悬液中,我们用单克隆抗体(Mab)Ki-67测定处于细胞周期的细胞比例,并用抗BrdU单克隆抗体在掺入溴脱氧尿苷(BrdU)后测定处于S期的细胞比例。在低度淋巴瘤中,3.5±1.6%的细胞处于细胞周期,1.2±0.9%处于S期,高度淋巴瘤的相应值分别为22.5±18.7%和8.9±7.8%。NHL冰冻切片与抗转铁蛋白受体(TR)抗体和Ki67反应,作为增殖活性的标志物。在所有组织学类型的低度淋巴瘤中均发现大量TR阳性细胞,而Ki67阳性与分级密切相关。除少数例外,低度淋巴瘤在肿瘤细胞群体中Ki67阳性细胞少于25%。这一观察结果与低度NHL的治疗策略相关。